Atea Pharmaceuticals Inc. (AVIR) at a glance

Atea Pharmaceuticals Inc. (AVIR) is a small-cap Healthcare company. It trades at $5.37, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 59/100 overall. Its strongest dimension is Safety (96/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$5.37

Market cap

$359.3M

P/E ratio

n/a

Dividend yield

None

Beta

0.32

52-week range

$2.78 to $6.45